Search

Cassavaugh, Jessica, Maria Serena Longhi, and Simon C Robson. 2025. “Impact of Estrogen on Purinergic Signaling in Microvascular Disease.”. International Journal of Molecular Sciences 26 (5).

Owings, Anna H, Sarah C Glover, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients With Inflammatory Bowel Disease.”. Digestive Diseases and Sciences 70 (3): 1248-49.

Abou-Donia, Mohamed B, Lisa A Conboy, Efi Kokkotou, Eric Jacobson, Eman M Elmasry, Passent Elkafrawy, Megan Neely, Cameron R Dale Bass, and Kimberly Sullivan. 2025. “Retraction Notice to ‘Screening for Novel Central Nervous System Biomarkers in Veterans With Gulf War Illness’ [Neurotoxicology and Teratology 61 (2017) 36-46].”. Neurotoxicology and Teratology 107: 107423.

Papamichael, Konstantinos, and Adam S Cheifetz. 2025. “Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?”. Alimentary Pharmacology & Therapeutics 61 (2): 369-70.

Burdine, Lauren K, Shana Rakowsky, Laurie Grossberg, Loren Rabinowitz, BIDMC IBD Research Center, Adam S Cheifetz, and Sarah Ballou. 2024. “Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think.”. Gastro Hep Advances 3 (8): 1135-37.

Vuerich, Marta, Du Hanh Nguyen, Davide Ferrari, and Maria Serena Longhi. 2024. “Adenosine-Mediated Immune Responses in Inflammatory Bowel Disease.”. Frontiers in Cell and Developmental Biology 12: 1429736.

Weissman, Simcha, Muhammad Aziz, Ayrton Bangolo, Vignesh K Nagesh, Htat Aung, Midhun Mathew, Lino Garcia, et al. 2024. “Global Geoepidemiology of Gastrointestinal Surgery Rates in Crohn’s Disease.”. World Journal of Gastrointestinal Surgery 16 (6): 1835-44.

Porth, Rachel, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Xavier Roblin, Stephane Paul, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.”. Inflammatory Bowel Diseases 31 (2): 485-91.

Gordon, Hannah, Silvia Minozzi, Uri Kopylov, Bram Verstockt, Maria Chaparro, Christianne Buskens, Janindra Warusavitarne, et al. 2024. “ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment.”. Journal of Crohn’s & Colitis 18 (10): 1531-55.

Papamichael, Konstantinos, Andrea Centritto, Lucas Guillo, Jessica Hier, Zachary Sherman, Adam S Cheifetz, and International Consortium of Therapeutic Drug Monitoring. 2024. “Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s Disease.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (10): 2134-2136.e2.